VERA THERAPEUTICS
Live / Registered — Registered (as of 17 Mar 2026)
What this means for you
Registered since 17 Mar 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 17 Mar 2032: the §8 declaration of use).
Record
- Serial number
- 88795772
- Registration number
- 8178474
- Mark type
- Word mark
- Filed
- 13 Feb 2020
- Published for opposition
- 13 Apr 2021
- Registered
- 17 Mar 2026
- Next maintenance filing
- §8 declaration of use, due by 17 Mar 2032 (grace period to 17 Sept 2032)
- Attorney of record
- JOHN PAUL OLEKSIUK
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of autoimmune and inflammation-related diseases; therapeutic preparations for the treatment of autoimmune and inflammation-related diseases
Owner
- VERA THERAPEUTICS, INC., Brisbane, CA, US
- VERA THERAPEUTICS, INC., Brisbane, CA, US
- VERA THERAPEUTICS, INC., SOUTH SAN FRANCISCO, CA, US
- TRUCODE GENE REPAIR, INC., South San Francisco, CA, US
Board proceedings on this mark
- Opposition No. 91272225 — Vera Whole Health, Inc. v. Vera Therapeutics, Inc., filed 11 Oct 2021 (Terminated)
- Extension of Time to Oppose No. 88795772 — Vera Whole Health, Inc. v. VERA THERAPEUTICS, INC., filed 07 May 2021 (Terminated)
Prosecution history
- 25 Mar 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 25 Mar 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 25 Mar 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 17 Mar 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 17 Mar 2026 — REGISTERED-PRINCIPAL REGISTER
- 24 Feb 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 24 Feb 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 23 Feb 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 23 Feb 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 23 Feb 2026 — ASSIGNED TO LIE
- 13 Feb 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 16 Dec 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 16 Dec 2025 — NON-FINAL ACTION E-MAILED
- 16 Dec 2025 — SU - NON-FINAL ACTION - WRITTEN
- 16 Dec 2025 — STATEMENT OF USE PROCESSING COMPLETE